NEWS RELEASES

Search all of our news releases here.

Try these: Jeff GalvinC. David PauzaHIVFDAAmerican Gene Technologies

American Gene Technologies announces the appointment of Dr. Mervyn Turner as chairman of the company’s scientific advisory board

Merv Turner to Chair American Gene Technologies’ Scientific Advisory Board

Jun 7, 2016

RENOWNED PHARMACEUTICAL STRATEGIST, MERV TURNER SEES GREAT PROMISE IN AGT’S EMERGING GENE THERAPY AND JOINS MANAGEMENT TO HELP GUIDE PRODUCTS TO COMMERCIALIZATION ROCKVILLE, MARYLAND (June 7, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Dr. Mervyn Turner as chairman of…

Read More
American Gene Technologies announces the appointment of Jonathan (Jon) Otterstatter to its board of directors

Leading Healthcare Innovator Joins Board of Directors of American Gene Technologies

May 24, 2016

  ADDITION OF JONATHAN OTTERSTATTER SIGNALS ADDITIONAL MOMENTUM FOR GENE THERAPY PIONEERS ROCKVILLE, MARYLAND (May 24, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Jonathan (Jon) Otterstatter to its board of directors. Otterstatter is co-founder, president and CEO of Preventice,…

Read More
American Gene Technologies announces its collaboration with Jerry Vockley, MD, PhD to accelerate AGT’s advancements in innovative genetic therapy for Phenylketonuria (PKU) and other inherited metabolic disorders

AGT Announces Collaboration with Internationally Recognized Leader in Medical Genetics

May 13, 2016

  JERRY VOCKLEY, MD, PHD COLLABORATES WITH AGT ON PHENYLKETONURIA (PKU) ROCKVILLE, Maryland. (May 13, 2016) – American Gene Technologies International, Inc. (AGT) today announced its collaboration with Jerry Vockley, MD, PhD, chief of the Division of Medical Genetics at Children’s Hospital of Pittsburgh of the…

Read More
Stuart B. Baker, MD has been appointed to the board of directors

American Gene Technologies Welcomes Visionary Leader to Board of Directors

Jan 27, 2016

ROCKVILLE, Md. (January 27, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Stuart B. Baker, MD to its board of directors. The latest addition to the emerging biotech’s roster of world-renowned experts comes on the heels of the addition of…

Read More

Subscribe to News Releases and News Updates

Subscribe to our news release and published article updates to be notified when we release new content!

Follow AGT on Social Media

AGT on Facebook

Tune in to Cell & Gene: The Podcast and hear Addimmune's Dr. Marcus Conant, a pioneer in HIV research, discuss our innovative cell therapy for HIV. He shares his vision for empowering patients and transforming HIV treatment. loom.ly/96TZ0jU#HIV #celltherapy #biotech ... See MoreSee Less
View on Facebook
M&A has been steady in 2024. We count 47 private & public deals to date totaling $53 billion. 15 have been >$1 billion with cancer, rare disease & cell therapies some of the areas of interest. ... See MoreSee Less
View on Facebook
AGT CEO, Jeff Galvin, had a chat with social media influencer and HIV advocate, Raif Derrazi, to discuss the latest updates on our AGT103-T clinical trials. Dive into the conversation as they shed light on the research and what lies ahead in our mission to find a cure for HIV! loom.ly/jAThqIU#HIV #hivcure #HIVresearch #clinicaltrials ... See MoreSee Less
View on Facebook
Can genetic evidence make drugs more effective? A new study in Nature suggests YES. Drug mechanisms with genetic support have a 2.6x higher chance of success. loom.ly/NxSxjXk#genetics #science #Healthcare ... See MoreSee Less
View on Facebook